Tissue distribution profiles of multiple major bioactive components in rats after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS
- PMID: 30255561
- DOI: 10.1002/bmc.4400
Tissue distribution profiles of multiple major bioactive components in rats after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS
Abstract
Xuebijing injection (XBJI) is a traditional Chinese medicine prescription extracted from five Chinese herbs. Hydroxysafflor yellow A, oxypaeoniflorin, ferulic acid and benzoylpaeoniflorin are the main bioactive ingredients of XBJI. This paper presents an application of ultra-high-performance liquid chromatography-Q-exactive hybrid quadrupole-Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) to quantify four compounds of XBJI in rats various tissues for tissue distribution studies. The analytes were separated on a Waters Acquity UHPLC® BEH C18 column with a gradient mobile phase consisting of acetonitrile-water (containing 0.1% formic acid) at a flow rate of 0.2 mL/min. Mass spectrometric detection was performed by parallel reaction monitoring via a heated electrospray ionization source under the negative ionization mode. The method was validated in various tissue samples, and has demonstrated great performance for rapidity, accuracy, high sensitivity and selectivity. It was successfully applied to the tissue distribution studies of XBJI after intravenous administration to rats. It was also the first study to investigate the tissue distribution of XBJI in rats and we found that the concentrations of four compounds were high in kidney, liver, stomach and intestine. The clinical use of XBJI should focus on its pharmacodynamics and safety studies in these tissues.
Keywords: UHPLC-Q-Orbitrap HRMS; Xuebijing injection; bioactive components; tissue distribution.
© 2018 John Wiley & Sons, Ltd.
Similar articles
-
Simultaneous determination and pharmacokinetic study of twelve bioactive compounds in rat plasma after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS.J Pharm Biomed Anal. 2017 Nov 30;146:347-353. doi: 10.1016/j.jpba.2017.09.010. Epub 2017 Sep 8. J Pharm Biomed Anal. 2017. PMID: 28918324
-
Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis.J Pharm Biomed Anal. 2017 Apr 15;137:220-228. doi: 10.1016/j.jpba.2017.01.024. Epub 2017 Jan 12. J Pharm Biomed Anal. 2017. PMID: 28147306
-
Determination of hydroxysafflor yellow A in biological fluids of patients with traumatic brain injury by UPLC-ESI-MS/MS after injection of Xuebijing.Biomed Chromatogr. 2014 Aug;28(8):1090-5. doi: 10.1002/bmc.3124. Epub 2014 Feb 17. Biomed Chromatogr. 2014. PMID: 24535782
-
A novel liquid chromatography Orbitrap mass spectrometry method with full scan for simultaneous determination of multiple bioactive constituents of Shenkang injection in rat tissues: Application to tissue distribution and pharmacokinetic studies.Biomed Chromatogr. 2018 Oct;32(10):e4306. doi: 10.1002/bmc.4306. Epub 2018 Jul 1. Biomed Chromatogr. 2018. PMID: 29879756
-
The Application of UHPLC-HRMS for Quality Control of Traditional Chinese Medicine.Front Pharmacol. 2022 Jun 2;13:922488. doi: 10.3389/fphar.2022.922488. eCollection 2022. Front Pharmacol. 2022. PMID: 35721122 Free PMC article. Review.
Cited by
-
Screening 89 Pesticides in Fishery Drugs by Ultrahigh Performance Liquid Chromatography Tandem Quadrupole-Orbitrap Mass Spectrometer.Molecules. 2019 Sep 17;24(18):3375. doi: 10.3390/molecules24183375. Molecules. 2019. PMID: 31533222 Free PMC article.
-
Therapeutic efficacy and mechanisms of Xuebijing in Acinetobacter baumannii infection based on meta-analysis and integrated pharmacology approaches.Front Pharmacol. 2025 May 23;16:1598359. doi: 10.3389/fphar.2025.1598359. eCollection 2025. Front Pharmacol. 2025. PMID: 40487407 Free PMC article.
-
Current status of traditional Chinese medicine for the treatment of COVID-19 in China.Chin Med. 2021 Jul 27;16(1):63. doi: 10.1186/s13020-021-00461-y. Chin Med. 2021. PMID: 34315521 Free PMC article. Review.
-
Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management.J Pharm Anal. 2022 Aug;12(4):664-682. doi: 10.1016/j.jpha.2022.01.001. Epub 2022 Jan 26. J Pharm Anal. 2022. PMID: 36105162 Free PMC article.
-
Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics.Int J Mol Sci. 2021 Oct 14;22(20):11078. doi: 10.3390/ijms222011078. Int J Mol Sci. 2021. PMID: 34681737 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
- 81873188/National Natural Science Foundation of China
- 182102310243/The key research and promotion project of Henan province
- 18A360022/The key scientific research project of Henan institution of higher education
- Foundation of the First Affiliated Hospital of Zhengzhou University
- HRJJ18002/Foundation of Hong Ri Medical Research
LinkOut - more resources
Full Text Sources
Other Literature Sources